UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 24, 2025
Accession Number:
0001193125-25-161191
Submission Type:
POS AM
CIK:
0001597264
Company Name:
Blueprint Medicines Corp
File Number:
333-211266